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The present study is an update review on the occurrence and diagnosis of rickettsial
diseases in Brazil and Portugal, aiming at promoting their epidemiological surveillance
in both countries. A literature review was carried out and unpublished data of laboratories
and surveillance systems were presented. The results described the occurrence of
rickettsial diseases and infections in Brazil and Portugal, including other new and still
poorly understood rickettsial infections. Current diagnostic methods were discussed.
As in many other countries, rickettsial diseases and infections seem to be an emerging
public health problem. Treated as a minor problem for many decades, the interest in
these infections has increased in both countries but further studies are needed to
establish their role as a public health problem.
INTRODUCTION
The initiative for an update emerged from a col-
laboration between institutions working on rickett-
sial disease research in Brazil and Portugal. The main
purpose of this study was to further knowledge on the
main rickettsial diseases found in both countries, aim-
ing mostly at developing new diagnostic approaches
and control strategies. Therefore, it is sought to pro-
mote increased knowledge exchange between both
countries in this field.
There is a growing concern in public health about
rickettsial diseases as they are transmitted by arthro-
pod vectors (ticks, fleas, lice and mites) and exist
worldwide in endemic foci.6
They are caused by bacteria of the family
Rickettsiaceae, comprising the genera Rickettsia,
Orientia, Coxiella, Bartonella (formerly Rocha-
limaea), Ehrlichia, and Anaplasma.6 The present re-
view focused on the genus Rickettsia only.
There is an increasing worldwide concern with hu-
man infections caused by the genus Rickettsia. In re-
cent years new species have been identified in several
countries, mostly because of improved detection power
of molecular biology techniques. Rickettsial infections
have very similar and overlapping clinical manifesta-
tions, making it difficult their etiological diagnosis.
Until recently no laboratory resources were available
to accurately differentiate rickettsial species. Species
differentiation is not even possible using in vitro cul-
ture, which is not available in most laboratories, as
different rickettsia species have nearly identical mor-
phological and biochemical characteristics.6,17,40
Public health experts have showed increasing in-
terest not only in identifying several new species and
describing their particular clinical manifestations but
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also because they have acknowledged rickettsial in-
fections have a higher occurrence and distribution
than previously thought.6,17,40
ETIOLOGY
Rickettsiae are Gram-negative obligate intracel-
lular microorganisms. Only few years ago, they were
considered to be “large viruses” as these bacteria
survive only inside cells, cannot be isolated in arti-
ficial media and have incomplete enzyme systems.
Humans are accidental hosts and they become the
final link in these bacteria life cycle, except in cases
of exanthematous typhus when humans act as their
reservoir.6,17,40
The genus Rickettsia is divided into two groups.
The first one, the typhus group, comprises three spe-
cies: R. prowazekii, the pathogen of epidemic exan-
thematous typhus; R. typhi, the pathogen of murine
typhus; and R. canadensis, which has been isolated
from ticks but not known to cause human infection.5,6
The second one, the spotted fever group, currently
comprises many serotypes. New rickettsiae have been
isolated in arthropods worldwide as well as in hu-
mans (R. africae and R. japonica). The species often
categorized in this group are: R. rickettsii, the patho-
gen of the Rocky Mountain spotted fever and the
Brazilian spotted fever; and R. conorii, which causes
the Mediterranean spotted fever, also known as
boutonneuse fever. The species R. sibirica, R. australis
and R. slovaca are among those not yet associated to
any particular clinical manifestations.4,6,19,26,32
It has been proposed to move the species R.
canadensis from the exanthematous typhus group to
create a new ancestral group, which would also in-
clude R. bellii.34
OCCURRENCE AND DISTRIBUTION OF
RICKETTSIAL DISEASES IN BRAZIL AND
PORTUGAL
Human rickettsial diseases that have been described
in Brazil and Portugal can be didactically classified
into three groups: classical, atypical, and new or re-
cently described.
Patients with classical rickettsial diseases present
with high fever of sudden onset and mostly exan-
thema. Some of them are considered cosmopolite dis-
eases, such as epidemic exanthematous typhus and
endemic or murine typhus being borne by vectors
such as body lice and flea, respectively. The epidemic
exanthematous typhus occurs in high altitudes of
Latin America (from Mexico to South America) and
Africa. Outbreaks of this disease form are easily iden-
tified and the literature has also described isolated
cases in travelers of endemic areas, which are detected
only when causing severe manifestations. Murine
typhus is an endemic form found in many islands and
port areas worldwide. In South America, it is associ-
ated with the existence of rats as reservoirs and hu-
mans are sporadically infected after being bitten by
the rat flea Xenopsylla cheopis.5,6
Epidemic exanthematous typhus, one of the first
rickettsial diseases described in humans, has never
been reported in Brazil. Brill-Zinsser disease, a recur-
rent form of epidemic exanthematous typhus, was
identified in Eastern European war refugees in the
early 1950’s. Reports from the late 19th century and
early 20th century suggest their clinical manifesta-
tions to be consistent with recurrent typhus, but no
laboratory confirmation is available.11,24
Only murine typhus of the exanthematous ty-
phus group has been described in Brazil in the
states of Minas Gerais, São Paulo and Rio de
Janeiro.2,15,25,30,36,38,39
Among rickettsial diseases of the spotted fever
group, the Brazilian spotted fever is the most preva-
lent and most lethal form. Their etiologic agents are
spotted fever group rickettsiae, and they are borne by
the anthropophilic tick Amblyomma cajennense. This
disease was first reported in 1929 in the state of São
Paulo,31 and cases have also been reported in Minas
Gerais, Rio de Janeiro, Espírito Santo, and Bahia.11,13-
15,20-22,35,38,*,** Only the states of Minas Gerais and
São Paulo have implemented a disease surveillance
system.
Minas Gerais had an incidence rate of 0.35 cases per
100,000 population between 1990 and 1994. From
1981 to 1994, the disease occurred mostly among males
aged five to 14 in the month of October and had 10%
fatality. Between 1995 and 2003, 106 cases were con-
firmed with a fatality rate of 18%.13,14,*
First described in the 1920’s in São Paulo, the first
disease focus was identified in an urban expansion
area, where today lie Sumaré and Perdizes neighbor-
hoods. Later, foci were reported in the suburban area
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Cruzes and Santo Amaro, but these foci disappeared
or became inactive as urban expansion progressed.
Today, in the state of São Paulo, there is only one
well-known focus in the area of Campinas (munici-
palities of Campinas, Pedreira, Jaguariúna and Santo
Antonio de Posse), in the basin of Atibaia and Jaguari
rivers, which has been expanding into the basin of
Piracicaba river.31,38,*
Until recently, only two cases had been described
outside the Campinas focus: one in Botucatu and the
other in Mogi das Cruzes. In the last years, however,
cases have been reported in the southern region of
Greater São Paulo, in the same areas where there were
reported cases in the 1950’s.11,13-15,20-22,35,38,**,***
Mandatory disease reporting was established for
the Campinas area in São Paulo in 1996 and nation-
wide in 2002. From 1985 to 2002, 76 cases were con-
firmed, 36 deaths reported with 47.6% fatality.*
In Portugal, among classic rickettsial diseases, en-
demic or murine typhus3,**** and, in the spotted fe-
ver group, Mediterranean spotted fever –also known
as escharo-nodular fever of Ricardo Jorge10,**** –
has been described. Murine typhus is endemic in the
Madeira archipelago, island of Porto Santo, and is
rarely diagnosed in the European continent.1,3,5,8-10,12,37
The only rickettsial disease of public health con-
cern in Portugal, Mediterranean spotted fever report-
ing has been mandatory since 1950. It is known to be
caused by R. conorii, which has been isolated, and
the disease is borne by the dog tick Rhipicephalus
sanguineus.1,3,5,8-10,12,37
From 1989 to 2000, the incidence rate of the Medi-
terranean spotted fever in Portugal was 9.8 cases per
100,000 population, which is one of the highest rates
in the Mediterranean basin. It has been evenly dis-
tributed among men and women and the highest rates
have been reported among those aged one to four,
i.e., 60 cases per 100,000 population. While most
cases are benign, severe cases and deaths have in-
creased in recent years in some districts. In 1999, the
disease fatality rate was 2.8%.7,10
The malign form of the Mediterranean spotted fe-
ver has increased in Portugal in the last three years
and has been identified in some hospital services.
Several bacteria have been isolated and it was possi-
ble to identify a strain of the R. conorii complex,
previously found only in Israel. The Mediterranean
spotted fever usually has a gradual onset as a flu-like
illness, no eschar is seen at the inoculation site and
skin exanthema is not typical as that found in R.
conorii infection. Multiorgan failure is a common
finding.1,7,37
The Center for Vector and Infectious Diseases Stud-
ies of Dr. Ricardo Jorge National Health Institute is
the national reference rickettsial laboratory in Portu-
gal. Over the last eight years (1995–2002) around
4,868 tests for R. conorii were performed using indi-
rect immunofluorescence, of which 10% were posi-
tive. During the same time, 453 whole blood samples
were tested and 31 strains of R. Conorii complex7,9,10
were isolated.
Atypical rickettsial diseases have ill-defined clini-
cal manifestations. The so-called apathogenic
rickettsiae would likely produce atypical manifesta-
tions and would go unnoticed not being either clini-
cally or laboratorially diagnosed. Most spotted fever
group rickettsiae are considered apathogenic as they
have not already been isolated in humans.4,6
Of these, R. bellii and R. amblyommii have been
detected in Brazil through molecular biology tech-
niques and tick isolation. Other molecular studies in
ticks and in human biological specimens from en-
demic areas have allowed detecting and describing
spotted fever group rickettsiae.14,18,27,*****
The third category comprises new rickettsial dis-
eases, namely: vesicular rickettsial infection (rickett-
sialpox), DEBONEL/TIBOLA (Dermacentor-borne
necrosis erythema and lymphadenopathy/tick-borne
lymphadenopathy), perimyocarditis and Rickettsia felis
rickettsiosis. Rickettsialpox has not yet been described
in either Brazil or Portugal. It is a benign illness devel-
oping about a week after the host is bitten by a parasite
mite of Mus musculus mouse. A non-tender erythema-
tous papule develops at the bite site, later forming a
vesicular lesion. Local lymphadenopathy and sudden
fever with chills may be associated with vesicular ex-
anthema, similar to the rash of varicella.
Rickettsia felis rickettsiosis has recently been de-
scribed in humans in the state of Minas Gerais. The cases
have been confirmed using serology and molecular bi-
ology and the pathogen has been detected in the vector
*Alexander Vranjac Center of Epidemiological Surveillance. Unpublished data.
**Galvão MAM. [Brazilian Spotted Fever in Minas Gerais and its determinants] (Master’s dissertation). Rio de Janeiro: Escola Nacional de Saúde Pública; 1988.
***Nascimento EMM. [Isolation and molecular detection of spotted fever group rickettsia from Amblyomma cajennense (Fabricius, 1787) and human biological samples, from
endemic areas of the state of São Paulo] (Master’s dissertation). São Paulo: Instituto de Ciências Biomédicas da Universidade de São Paulo; 2003.
****Bacellar F. [Rickettsias isolated in Portugal. Contribution to strain identification and classification] (doctorate thesis). Évora: Universidade de Évora; 1996.
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18th Meeting American Society for Rickettsiology; 2003; Cumberland, MD. Maryland; 2003.
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through molecular biology. The etiologic agent is R.
felis, which is borne by a flea of the genus Ctenocephali-
des. This rickettsial disease is included in the spotted
fever group due its phylogenetic characteristics, but it
has not yet been isolated in humans.4,9,14,19,27
DEBONEL/TIBOLA or tick-borne lymphadenopa-
thy is caused by Dermacentor tick bite and has been
recently described by Raoult et al32 in France, Lakos19
in Hungary and Oteo et al28 in Spain. Its pathogen, R.
slovaca, is borne by the Dermacentor marginatus
vector. In Portugal, this tick is often parasited by rick-
ettsia and frequently found in cows and wild boars.
Clinical manifestations in humans are characterized
by local rash at the bite site, commonly in the scalp,
associated with cervical and submandibular lymphad-
enopathy. The rash starts as a papule or vesicle and
develops into an exudative necrotic lesion later pro-
gressing into a crust and alopecia. Low fever can per-
sist for months and alopecia can persist for years.
Perimyocarditis is caused by Rickettsia spp. and, in
Sweden, it has been described as causing death in young
adults.26 The etiologic agent seems to be R. helvetica
and its vector Ixodes ricinus, both found in Portugal.*
LABORATORIAL DIAGNOSIS
Since Weil & Felix breakthrough in 1921, the labo-
ratorial diagnosis of rickettsial diseases relies on rela-
tively unspecific serology testing. Diagnosis is made
through an agglutination reaction with sera of epi-
demic exanthematous typhus patients and strains of
Proteus sp. and, following the 1987 World Health
Organization (WHO) recommendation, indirect im-
munofluorescence with specific antigens.40,**
Direct methods can be used for detecting rickettsiae
in tissue biopsies or organ autopsies by isolating them
from cell cultures, histochemistry, and genotype iden-
tification using molecular biology.
SEROLOGY DIAGNOSIS
The Weil-Felix reaction is a low-cost and easy-to-
perform method. It detects agglutinating antibodies
in patients sera, which react with different Proteus
strains or species. Each Proteus species has antigen
epitopes similar to membrane lipopolysaccharides of
different group rickettsiae. The agglutinins, which
are detectable from five to ten days after symptom
onset, are IgM immunoglobulins. Exanthematous
typhus group rickettsiae preferentially react with Pro-
teus vulgaris OX19, while most spotted fever group
rickettsiae, except for R. akari, preferentially react
with Proteus OX2. This diagnostic method cannot be
used in Brill-Zinsser patients – recrudescent epidemic
typhus – as they do not produce IgM. In addition, as
antigens are unspecific, cross-reaction have been
described, mostly in sera of patients who have al-
ready been infected by both Proteus and other α-
proteobacteria with similar antigen epitopes, such as
Legionella spp. and Brucella spp.40
Recommended by the WHO as the gold standard for
rickettsial disease diagnosis, indirect immunofluores-
cence (IIF) use species-specific antigens of Rickettsia.
IgM detection strongly evidences an active rickettsial
infection but its diagnosis can be masked by the pro-
zone phenomenon, and affected by rheumatoid factor
and autoantibodies. Besides, there are also cross-reac-
tions between exanthematous typhus and spotted fe-
ver group rickettsiae. IgG antibodies can be detected
about a week after disease onset, they are specific in
their biogroup and can persist up to four years.40
The use of antibiotics, whether specific or not, to
treat rickettsial diseases can also interfere with the
results, though to a lesser extent than in the aggluti-
nation reaction. Low or even undetectable antibody
titers in dilutions used as a positive cut-off can pro-
duce false negative results. However, IIF can cross-
react with species of the same group, making it diffi-
cult to accurately identify species either of exanthe-
matous typhus or spotted fever group. In this case,
one has to rely on clinical and epidemiological evi-
dences for diagnostic confirmation.40
Other serology testing has been used for diagnosing
rickettsial diseases, but they are hardly reproducible,
e.g., ELISA and Western blot. These techniques require
purified antigens, which are not available in many pub-
lic health laboratories. Western blot test is considered
more sensitive than IIF providing early IgM detection.
Presumably, it is a more specific method, recommended
for epidemiological studies investigating actual infec-
tion prevalence. However, the amount and purity of an-
tigen required hinder its use as a routine method.**
DIRECT METHODS
After the etiologic agent is isolated, it can be identi-
fied through several methods. This can be performed
by laboratories using viral isolation from in vitro cell
cultures. The safety level required for rickettsiae are





Riquetsial diseases in Brazil and Portugal
Galvão MAM et al
rickettsiae may remain viable when isolated, samples
should be collected before starting with antibiotic treat-
ment and be kept refrigerated and tested as soon as
possible. Samples include blood with anticlotting
agents, plasma, and biopsy and autopsy material. The
most common method used is called “shell vial as-
say”, adapted from the rickettsia study by the Unité
des Rickettsies de Marseille group. The inconvenience
for the patient is the time elapsed between sample col-
lection and diagnosis. Definitive diagnosis takes about
15 days because this is a lengthy procedure.23,*
Rickettsia detection and identification using molecu-
lar biology require properly collected samples. This tech-
nique can also be used for identifying isolated strains
and consists of the amplification of a genoma segment
shared by all rickettsiae codifying the 17-kDa antigen
gene, and/or the citrate synthase enzyme (gtlA) gene,
which condenses acetyl-CoA with oxaloacetate to form
citrate in the citric acid cycle. Gene sequences codify-
ing the membrane surface proteins Omp found in the
spotted fever group rickettsiae, such as rOmp A and rOmp
B, can also be used. After amplification, restriction en-
zymes break down gene segments and species-specific
fragment maps are produced.23 Technology advance-
ments have virtually made all these procedures auto-
mated and allowed for direct sequencing of nucleotide
bases of each segment and quickly and accurately iden-
tifying every rickettsia species. Such identification is
possible through comparison of genomic database, such
as GeneBank.33,* There are, however, many deleterious
factors associated with sample collection and preserva-
tion, e.g., action of DNAses, RNAses, inhibition by Fe+2
or heparin, which yield false negative results.
Molecular biology techniques will be likely be the
first choice in the near future when equipment and
reagents should be more affordable, and sample col-
lection and preservation conditions would be prop-
erly optimized.
Immunohistochemistry can be experimentally used
in several reference laboratories. But, if needed, any
clinical pathology laboratory can implement it. His-
tological sections of skin or other tissues are sub-
jected to the action of anti-rickettsiae (monoclonal
or polyclonal) antibodies produced by laboratory
animals. Antibody binding to antigen can be seen by
peroxidase staining or fluorescence.16,29,*
Final considerations
As a conclusion, many techniques can, and should
be, used in the laboratorial diagnosis of rickettsial dis-
eases as well as effective epidemiological surveillance
of cases. In some geographical areas, where the occur-
rence of certain rickettsiae is still unknown, this ap-
proach presumably requires searching for these bacte-
ria in arthropod vectors. In cases of atypical rickettsial
diseases with strong epidemiological suggestion of
infection, all known diagnostic methods should be
applied, even in the face of no clinical evidence. Using
antigens from strains locally isolated increase sero-
logy specificity. In countries such as Brazil and Portu-
gal, where suspected clinical cases of rickettsiae are
reported every year, rapid and effective diagnosis is
key and crucial to avoid treatment delays. It is empha-
sized, however, that clinical evaluation is still the fast-
est and the most valuable diagnostic tool available.
*Nascimento EMM. [Isolation and molecular detection of spotted fever group rickettsia from Amblyomma cajennense (Fabricius, 1787) and human biological samples, from
endemic areas of the state of São Paulo] (Master’s dissertation). São Paulo: Instituto de Ciências Biomédicas da Universidade de São Paulo; 2003.
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